BioIntelliSense announced today that it acquired AlertWatch, an FDA-cleared patient monitoring platform. AlertWatch offers integration, data analysis and a patented display of contextual patient data to help in clinical decision-making. BioIntelliSense in August partnered with Medtronic on the distribution of patient monitoring technology. Through this partnership, it intends to distribute AlertWatch to hospitals throughout the […]
